Bachisio Ziccheddu

Sylvester Comprehensive Cancer Center, University of Miami

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Esteban Braggio

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Brian Walker

Indiana State University

UNITED STATES

View details

David G. Coffey

Assistant Professor

University of Miami School of Medicine

UNITED STATES

View details

Lukas John

Deutsches Krebsforschungszentrum

GERMANY

View details

Oliver Hampton

Chief Data Officer

Southwest Research Institute

UNITED STATES

View details

Saad Usmani

Chief Attending

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bachisio Ziccheddu

Research Interests

Explore related searches

Contact this professor

Articles (10)

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.

Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma

Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.

The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.

Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma.

Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma

Genomic Classification and Individualized Prognosis in Multiple Myeloma.

Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.

Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma.

Collaborators (6)

Esteban Braggio

Brian Walker

David G. Coffey

Lukas John

Oliver Hampton

Saad Usmani

Make your next move.